Indicators / series
cnbc.openevidence.revenue_run_rate_usd.pt
Source: CNBC (CNBC LLC) · CNBC; short quotation · CSV
CNBC
| id | value | grade | as of date | published date | tier | audited vs reported | extraction method | review status | retrieved at | http status | content hash | supersedes id | url | flags |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ab4c1a4c712aa477 | $100M | grade C, evidence tier 5 | 2025-12-31 | 2026-01-21 | 5 | company_stated | manual | approved | 2026-09-25 02:54 | 200 | f75bb206ac72 | — | source page | ⚑ disputed: An annualised month reported by the press or the company, not booked or audited revenue, and often sourced to the companrun_rate 'topped $100 million' stored as floor; 'last year' read as end-2025. Mostly pharma/device advertising revenue. |
Raw snippets and dispute text
- ab4c1a4c712aa477 OpenEvidence said it topped $100 million in annualized revenue last year, mostly fueled by organic growth. — An annualised month reported by the press or the company, not booked or audited revenue, and often sourced to the company itself.